Syntropharma is a specialty pharmaceutical company that develops prescription medicines for diseases affecting the central nervous system.
Description
Syntropharma is an emerging pharmaceutical company focussed on taking commercially successful generic compounds and improving their clinical profile by reformulating them as patch applications which are applied to the skin. Its vision is to develop a stream of first and second to market transdermal products with strong IP that will be out-licensed to pharmaceutical company partners.
Total funding
$$3123123
Sign in for full access
Location
Newtown Saint Boswells, Scottish Borders, The, United Kingdom, Europe